In last week’s Sunday Digest, I (Tom Yeung) wrote how cyclical companies are often incredible investments. Firms like copper ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The Ibn Sina Pharmaceutical Industry's profit grew marginally in the second quarter of fiscal year 2024-25. The company's ...

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Minot Light Capital, an investment management firm, recently released its fourth-quarter 2024 investor letter. A copy of the ...

Investing.com -- Shares of Laser Photonics Corporation (NASDAQ: LASE) climbed 3% after the company's subsidiary, Control Micro Systems (CMS), announced receiving follow-on orders from clients in the ...

IST, the barometer index, the S&P BSE Sensex, shed 45.42 points or 0.07% to 76,474.96. The Nifty 50 index fell 20.60 points or 0.09% to 23,184.75.

Stocks including Kotak Mahindra Bank, Dr Reddy's Labs, Adani Green, IndiGo, Indus Towers, United Spirits, Mankind Pharma and more will be in the spotlight on Friday, January 24.

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...